---
created: 2025-04-13
updated: 2025-04-13T10:52
id: g~`([*x4Do
specialty: pharmaco
specialty_id: 320
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::01-biochemistry::05-nutrition::04-vitamin-a
  - "source/ak-step1-v11:": 
  - theme/firstaid::01-biochemistry::05-nutrition::04-vitamin-a::function
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::04-pathology::28-leukemia::acute-leukemia::acute-myelogenous-leukemia::acute-promyelocytic-leukemia
  - "source/ak-step1-v11:": 
  - source/ome-banner
  - "source/ak-step1-v11:": 
  - theme/physeo::06-micro::05-viruses::31-measles
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::08-antineoplastics::retinoids-bcg
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^fa-updates::fa2017
  - source/ak-step1-v11::^other::^highyield::1-highyield"
type: flashcard
---

# Question
All-trans retinoic acid can be used to treat the **measles** virus

---

# Answer
This is done via binding the Retinoic Acid Receptor-a (RAR-a), which forms a transcription complex that induces transcription of RIG-1, therefore when measles RNA is in the cell, RIG-1 will recognize it and stimulate expression and production of antiviral type I interferons (IFN-a / IFN-B)